ReviewOncoTargets and therapy2023

Targeted Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL): Tafasitamab in Context.

Haifaa Abdulhaq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.